Senior Statistical Analyst - RWE - SAS programming
ICON plc
Summary
As a Senior Statistical Analyst at ICON, you will develop and validate analysis datasets, tables, listings and figures.
Job description
What You Will Do
- Develop and validate analysis datasets, tables, listings and figures.
- Apply programming standards and specifications consistently.
- Perform quality control and resolve data or programming issues.
- Collaborate with biostatistics, data management and clinical stakeholders.
- Maintain traceable programming documentation and submission readiness.
- Provide technical guidance, peer review or mentoring on complex work within the discipline.
Required qualifications and experience
- Degree in statistics, mathematics, computer science or related quantitative discipline, or equivalent relevant programming expertise.
- Minimum of 5 years of experience in statistical analysis within the pharmaceutical, biotechnology, or CRO industry.
- Proficiency in statistical software SAS (R or Python are also used in a more limited capacity).
- Understanding of clinical trial design, statistical methodologies, and regulatory requirements.
- Practical statistical programming experience in clinical trials using SAS or another appropriate statistical programming environment.
- Knowledge of CDISC SDTM and ADaM standards.
- Understanding of clinical trial data, statistical outputs and validation practices.
- Experience developing and validating analysis datasets, tables, listings and figures.
- Experience reviewing colleagues' work and providing technical guidance on clinical statistical programming.
Preferred qualifications and experience
- Experience supporting regulatory submissions.
- SAS programming capability (R or Python are also used in a more limited capacity).
- Advanced CDISC or Define XML expertise.
Requirements
- Degree in statistics, mathematics, computer science or related quantitative discipline, or equivalent relevant programming expertise
- Minimum of 5 years of experience in statistical analysis within the pharmaceutical, biotechnology, or CRO industry
- Proficiency in statistical software SAS
- Understanding of clinical trial design, statistical methodologies, and regulatory requirements
- Practical statistical programming experience in clinical trials using SAS or another appropriate statistical programming environment
- Knowledge of CDISC SDTM and ADaM standards
- Understanding of clinical trial data, statistical outputs and validation practices
- Experience developing and validating analysis datasets, tables, listings and figures
- Experience reviewing colleagues' work and providing technical guidance on clinical statistical programming
- Experience supporting regulatory submissions
- Advanced CDISC or Define XML expertise
Benefits
- Competitive base salary
- Performance related incentives
- Medical, Dental & Vision
- Retirement and pension plans
- Life assurance
- Disability coverage
- Employee assistance programmes
- Wellbeing resources
- Learning and development opportunities
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.